TY - JOUR
T1 - Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction
T2 - Techniques and Functional Outcomes in Males
AU - Martini, Alberto
AU - Falagario, Ugo Giovanni
AU - Russo, Antonio
AU - Mertens, Laura S.
AU - di Gianfrancesco, Luca
AU - Bravi, Carlo Andrea
AU - Vollemaere, Jonathan
AU - Abdeen, Muhammad
AU - Mendrek, Mikolaj
AU - Kjøbli, Eirik
AU - Buse, Stephan
AU - Wijburg, Carl
AU - Touzani, Alae
AU - Ploussard, Guillaume
AU - Antonelli, Alessandro
AU - Schwenk, Laura
AU - Ebbing, Jan
AU - Vasdev, Nikhil
AU - Froelicher, Gabriel
AU - John, Hubert
AU - Canda, Abdullah Erdem
AU - Balbay, Mevlana Derya
AU - Stoll, Marcel
AU - Edeling, Sebastian
AU - Witt, Jorn H.
AU - Leyh-Bannurah, Sami-Ramzi
AU - Siemer, Stefan
AU - Stoeckle, Michael
AU - Mottrie, Alexander
AU - D'Hondt, Frederiek
AU - Crestani, Alessandro
AU - Porreca, Angelo
AU - van der Poel, Hendrik
AU - Scientific Working Group of the Robotic Urology Section of the European Association of Urology
AU - Decaestecker, Karel
AU - Gaston, Richard
AU - Peter Wiklund, N.
AU - Hosseini, Abolfazl
N1 - Funding Information:
For the present study, data were collected from high-volume robotic surgical centers across Europe. For the scope of the study, we included only male patients who underwent RARC with neobladder reconstruction and had at least 12 mo of follow-up. The project was sponsored by the Scientific Working Group of the Robotic Urology Section of the EAU.
Publisher Copyright:
© 2023 The Author(s)
PY - 2023
Y1 - 2023
N2 - Background: Little is known regarding functional outcomes after robot-assisted radical cystectomy (RARC) and intracorporeal neobladder (ICNB) reconstruction. Objective: To report on urinary continence (UC) and erectile function (EF) at 12 mo after RARC and ICNB reconstruction and investigate predictors of these outcomes. Design, setting, and participants: We used data from a multi-institutional database of patients who underwent RARC and ICNB reconstruction for bladder cancer. Surgical procedure: The cystoprostatectomy sensu stricto followed the conventional steps. ICNB reconstruction was performed at the physician's discretion according to the Studer/Wiklund, S pouch, Gaston, vescica ileale Padovana, or Hautmann technique. The techniques are detailed in the video accompanying the article. Measurements: The outcomes measured were UC and EF at 12 mo. Results and limitations: A total of 732 male patients were identified with a median age at diagnosis of 64 yr (interquartile range 58–70). The ICNB reconstruction technique was Studer/Wiklund in 74%, S pouch in 1.5%, Gaston in 19%, vescica ileale Padovana in 1.5%, and Hautmann in 4% of cases. The 12-mo UC rate was 86% for daytime and 66% for nighttime continence, including patients who reported the use of a safety pad (20% and 32%, respectively). The 12-mo EF rate was 55%, including men who reported potency with the aid of phosphodiesterase type 5 inhibitors (24%). After adjusting for potential confounders, neobladder type was not associated with UC. Unilateral nerve-sparing (odds ratio [OR] 3.85, 95% confidence interval [CI] 1.88–7.85; p < 0.001) and bilateral nerve-sparing (OR 6.25, 95% CI 3.55–11.0; p < 0.001), were positively associated with EF, whereas age (OR 0.93, 95% CI 0.91–0.95; p < 0.001) and an American Society of Anesthesiologists score of 3 (OR 0.46, 95% CI 0.25–0.89; p < 0.02) were inversely associated with EF. Conclusions: RARC and ICNB reconstruction are generally associated with good functional outcomes in terms of UC. EF is highly affected by the degree of nerve preservation, age, and comorbidities. Patient summary: We investigated functional outcomes after robot-assisted removal of the bladder in terms of urinary continence and erectile function. We found that, in general, patients have relatively good functional outcomes at 12 months after surgery.
AB - Background: Little is known regarding functional outcomes after robot-assisted radical cystectomy (RARC) and intracorporeal neobladder (ICNB) reconstruction. Objective: To report on urinary continence (UC) and erectile function (EF) at 12 mo after RARC and ICNB reconstruction and investigate predictors of these outcomes. Design, setting, and participants: We used data from a multi-institutional database of patients who underwent RARC and ICNB reconstruction for bladder cancer. Surgical procedure: The cystoprostatectomy sensu stricto followed the conventional steps. ICNB reconstruction was performed at the physician's discretion according to the Studer/Wiklund, S pouch, Gaston, vescica ileale Padovana, or Hautmann technique. The techniques are detailed in the video accompanying the article. Measurements: The outcomes measured were UC and EF at 12 mo. Results and limitations: A total of 732 male patients were identified with a median age at diagnosis of 64 yr (interquartile range 58–70). The ICNB reconstruction technique was Studer/Wiklund in 74%, S pouch in 1.5%, Gaston in 19%, vescica ileale Padovana in 1.5%, and Hautmann in 4% of cases. The 12-mo UC rate was 86% for daytime and 66% for nighttime continence, including patients who reported the use of a safety pad (20% and 32%, respectively). The 12-mo EF rate was 55%, including men who reported potency with the aid of phosphodiesterase type 5 inhibitors (24%). After adjusting for potential confounders, neobladder type was not associated with UC. Unilateral nerve-sparing (odds ratio [OR] 3.85, 95% confidence interval [CI] 1.88–7.85; p < 0.001) and bilateral nerve-sparing (OR 6.25, 95% CI 3.55–11.0; p < 0.001), were positively associated with EF, whereas age (OR 0.93, 95% CI 0.91–0.95; p < 0.001) and an American Society of Anesthesiologists score of 3 (OR 0.46, 95% CI 0.25–0.89; p < 0.02) were inversely associated with EF. Conclusions: RARC and ICNB reconstruction are generally associated with good functional outcomes in terms of UC. EF is highly affected by the degree of nerve preservation, age, and comorbidities. Patient summary: We investigated functional outcomes after robot-assisted removal of the bladder in terms of urinary continence and erectile function. We found that, in general, patients have relatively good functional outcomes at 12 months after surgery.
KW - Bladder cancer
KW - Functional outcomes
KW - Robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=85153586279&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2023.04.009
DO - 10.1016/j.eururo.2023.04.009
M3 - Article
C2 - 37117109
SN - 0302-2838
JO - European Urology
JF - European Urology
ER -